Figure 1.
DFS of early-stage BRAF-positive NSCLC patients (A), PFS of first-line regimens in patients with BRAF-positive NSCLC (B). DFS, disease-free survival; PFS, progression-free survival. Tick marks indicate censored observations.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.